Intelligence Β· Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors β phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text β searchable for business development and competitive intelligence.
-
Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed), Gardasil 9 suspension for injection. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed), Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed), Placebo formulation of Gardasil, Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed)
The George Institute
Patients with primary HPV high-grade squamous intra-epithelial lesions (HSIL) at any site (vulvar VIN, vaginal VaIN, penile (PeIN), cervical CIN, anal AIN) at the time of treatment.
1 trial -
Gardasil 9 suspension for injection in a pre-filled syringe. Human Papillomavirus 9-valent Vaccine (Recombinant, adsorbed), Gardasil, suspension for injection in a pre-filled syringe Human Papillomavirus Vaccine [Types 6, 11, 16, 18] (Recombinant, adsorbed), SODIUM CHLORIDE
Pari Pharma GmbH
External Genital Warts (EGW)
1 trial -
Glecaprevir/Pibrentasvir
AbbVie
Hepatitis C Virus (HCV)
2 trials -
Gynaecological follow-up
GlaxoSmithKline
Infections, Papillomavirus
1 trial -
H5N1 adjuvanted split virus vaccine (A/Vietnam/1194/2004 strain)
GlaxoSmithKline
Influenza
1 trial -
Human Norovirus Bivalent (Gβ .1/Gβ ‘.4)VaccineοΌRecombinant (Hansenula polymorpha)
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Norovirus Infections
1 trial -
Human Plasma-Derived Coagulation Factor VIII Concentrate (Virus Inactivated by Polysorbate 80 Treatment and Vapor Heat Treatment)
Takeda
Hemophilia A
1 trial -
Human rotavirus liquid vaccine
GlaxoSmithKline
Infections, Rotavirus
1 trial -
INO-4800
INOVIO PHARMACEUTICALS, INC.
Coronavirus Infection
4 trials -
Influenza A (H5N1) Virus monovalent vaccine
GlaxoSmithKline
Influenza
1 trial -
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
Sinovac Research and Development Co.,
Seasonal Influenza
1 trial -
Influenza Virus Vaccine
Seqirus (Australia) Pty Ltd
Influenza
1 trial -
Isoniazid with Ethambutol
United Therapeutics Europe Ltd
Human Immunodeficiency Virus
1 trial -
LAMIVUDINE AND DOLUTEGRAVIR , DARUNAVIR , DORAVIRINE , DARUNAVIR AND COBICISTAT , EMTRICITABINE, TENOFOVIR ALAFENAMIDE, DARUNAVIR AND COBICISTAT, TENOFOVIR ALAFENAMIDE , RITONAVIR , ISLATRAVIR/LENACAPAVIR, LAMIVUDINE, ABACAVIR AND DOLUTEGRAVIR, EMTRICITABINE, TENOFOVIR ALAFENAMIDE, ELVITEGRAVIR AND COBICISTAT, EMTRICITABINE, RALTEGRAVIR , EMTRICITABINE, TENOFOVIR ALAFENAMIDE AND BICTEGRAVIR, EMTRICITABINE, TENOFOVIR DISOPROXIL AND RILPIVIRINE, DOLUTEGRAVIR , LAMIVUDINE, TENOFOVIR DISOPROXIL AND DORAVIRINE,
Gilead Sciences Pty Limited
HIV-1 Infection
1 trial -
LDV/SOF
Gilead Sciences Ireland UC
Hepatitis C Virus
1 trial -
LY3819253
Vir Biotechnology
Covid19
1 trial -
Live Attenuated Respiratory Syncytial Virus (RSV) βNS2/β1313/I1314L vaccine, Matched
Sanofi-aventis Healthcare Pty Ltd
Virus diseases
1 trial -
Live attenuated Japanese encephalitis chimeric virus vaccine
Sanofi Pasteur
Japanese Encephalitis
1 trial -
Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus
Sanofi Pasteur
Dengue Fever
1 trial -
MK-8527
Merck KGaA, Darmstadt, Germany
Human Immunodeficiency Virus (HIV)
1 trial -
MYCOPHENOLIC ACID, -, MYCOPHENOLATE MOFETIL, VAY736, TENOFOVIR ALAFENAMIDE , ENTECAVIR , TENOFOVIR DISOPROXIL
Novartis Pharmaceuticals
Lupus nephritis
1 trial -
MYCOPHENOLIC ACID, TENOFOVIR ALAFENAMIDE , Placebo to VAY736 150 mg/1 mL Solution for injection in pre-filled syringeβ―, Placebo to VAY736 300 mg/2 mL Solution for injection in pre-filled syringe, VAY736, ENTECAVIR , -, TENOFOVIR DISOPROXIL , VAY736, MYCOPHENOLATE MOFETIL
Novartis Pharmaceuticals
Lupus nephritis
1 trial -
Maribavir
Takeda
Cytomegalovirus (CMV)
6 trials -
Maribavir
Shire
Cytomegalovirus (CMV)
2 trials
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1β3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync β verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources